Clinical Trials Directory

Trials / Sponsors / Antisoma Research

Antisoma Research

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Ac
Acute Myeloid Leukemia
Phase 22010-01-01
UnknownA Pharmacokinetic and Efficacy Study of Amonafide L-malate (AS1413) in Combination With Cytarabine in Patients
Acute Myeloid Leukemia
Phase 22010-01-01
TerminatedPhase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer
Breast Carcinoma
Phase 22008-09-01
UnknownA Phase II Study of AS1411 in Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Phase 22008-08-01
CompletedStudy of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma
Metastatic Renal Cell Carcinoma, Metastatic Malignant Melanoma
Phase 12008-01-01
CompletedPhase II Study of AS1411 Combined With Cytarabine to Treat Acute Myeloid Leukemia
Leukemia, Myeloid
Phase 22007-07-01
UnknownPhase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients
Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
Phase 32007-06-01
CompletedStudy of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
Prostate Cancer
Phase 22005-05-01
CompletedPhase II Study of DMXAA (ASA404) in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lun
Non-Small Cell Lung Cancer
Phase 1 / Phase 22004-09-01
CompletedStudy of AS1411 in Advanced Solid Tumours
Advanced Solid Tumors
Phase 12003-09-01
CompletedPhase I Safety Study of DMXAA in Refractory Tumors
Refractory Tumors
Phase 12003-05-01